Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management.
Ontology highlight
ABSTRACT: The objective of the present study was to review the essential knowledge about the combinations of the most commonly used or under development targeted treatments and radiation therapy (RT). Preclinical and clinical studies investigating this combination were extensively reviewed. Several studies showed that the combination of RT and tamoxifen increased the risk of radiation-induced pulmonary toxicity; therefore, both modalities should not be given concomitantly. The combination of HER2 inhibitors (trastuzumab, pertuzumab) and RT seems to be safe. However, trastuzumab emtansine (T-DM1) should not be administered concurrently with brain RT since this combination could increase the risk of brain radionecrosis. The combination of RT and other new target treatments such as selective estrogen r
SUBMITTER: Beddok A
PROVIDER: S-EPMC8699586 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA